AMD's current strategy is probably best summed up by Sander's mantra: "Volume is the vaccine". AMD continues its march towards a duopoly undeterred, although clearly not unaffected, by the harsh conditions on the battle field.
Wow, one can almost hear the battlefield of republic
playing in the background reading your drivel.
Here's the facts Chester: AMD uses expensive process
tech to try to gain a performance advantage over Intel.
Through better MPU design and implementation and
earlier access to smaller feature size but lower cost
processes (bulk instead of SOI, fewer layers of metal,
one class of device etc) Intel has better products that
are less costly to manufacture than AMD's but fetch
better prices and even better margins.
AMD is running at a brick wall with its flood the market
strategy with an inferior product. The harder AMD runs
at that wall the more damage it does to itself, not the
wall. By building fab capacity beyond its ability to fill
with well paying devices AMD is raising its costs with
volume not lowering it. And its borrowing to do so.
News 
Market Data 
Discover 
AI
